U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951984) titled 'Hydroxyephedrine PET/CT in Sympathetic Nervous System Disease' on April 23.
Brief Summary: To evaluate the potential usefulness of 11C/18F-HED positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.
Study Start Date: March 01, 2013
Study Type: OBSERVATIONAL
Condition:
Sympathetic Nervous System Diseases
Sympathetic Nervous Structure Injury
Sympathetic Nerve Injury
Intervention:
DIAGNOSTIC_TEST: 11C/18F-HED
Each subject receive a single intravenous injection of 11C/18F-HED and undergo PET/CT or MRI imaging within the specificed time....